
Overview
Jun Abella, NP is a Family Health Nurse Practitioner in the division of Gynecologic Oncology at NewYork-Presbyterian/Columbia University Irving Medical Center. Before joining Columbia in 2022, she previously served at Good Samaritan in Medical Oncology, Mount Sinai Oncology Clinical trials, and NYU Nephrology and Cardiology. She now specializes in caring for patient with gynecologic issues and gynecologic cancers.
Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Severe Congenital Neutropenia.
Abella, NP is board certified in ANCC Family Nurse Practitioner. Abella, NP is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
161 Fort Washington Avenue, New York, NY 10032
Additional Areas of Focus
Abella has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Barbara Pro is an Oncologist practicing medicine in New York, New York. Dr. Pro is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Pro is currently accepting new patients.
CUIMC/Neurological Institute Of New York
Fabio Iwamoto is an Oncologist practicing medicine in New York, New York. Dr. Iwamoto is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Iwamoto is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Jason Wright is an Obstetrics and Gynecologist practicing medicine in New York, New York. Dr. Wright is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Oophorectomy. Dr. Wright is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia. She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases. She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Lamanna is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy. Dr. Lamanna is board certified in Medical Oncology. Dr. Lamanna is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.
Frequently Asked Questions about Jun R. Abella, NP
Is Jun R. Abella, NP a top-rated expert for Paget Disease of the Breast?
MediFind is an objective health platform that identifies experts based on real-world data. Jun R. Abella, NP is classified as an Experienced expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Jun R. Abella, NP specialize in?
While Jun R. Abella, NP is a Obstetrics and Gynecology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.
Does Jun R. Abella, NP accept my insurance?
Jun R. Abella, NP accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisAbella, NP isExperienced. Learn about Agranulocytosis.
- AngiosarcomaAbella, NP isExperienced. Learn about Angiosarcoma.
- Breast CancerAbella, NP isExperienced. Learn about Breast Cancer.
- Chronic Familial NeutropeniaAbella, NP isExperienced. Learn about Chronic Familial Neutropenia.
- Colorectal CancerAbella, NP isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerAbella, NP isExperienced. Learn about Familial Colorectal Cancer.
- HER-2 Positive Breast CancerAbella, NP isExperienced. Learn about HER-2 Positive Breast Cancer.
- Inflammatory Breast CancerAbella, NP isExperienced. Learn about Inflammatory Breast Cancer.
- Lynch SyndromeAbella, NP isExperienced. Learn about Lynch Syndrome.
- Paget Disease of the BreastAbella, NP isExperienced. Learn about Paget Disease of the Breast.
- Severe Congenital NeutropeniaAbella, NP isExperienced. Learn about Severe Congenital Neutropenia.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)


